Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yves Pastore

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
The Journal of Allergy and Clinical Immunology. in Practice|June 29, 2023
A novel variant in caspase recruitment domain family member 11 highlights the variability of clinical manifestations and management in a three generation familyGuilhem Cros, Hugo Chapdelaine, Pierre Teira, et al.
British Journal of Clinical Pharmacology|June 14, 2020
The timing of cyclic cytotoxic chemotherapy can worsen neutropenia and neutrophiliaMichael C Mackey, Sanja Glisovic, Jean-Marie Leclerc, et al.
Paediatrics & Child Health|August 9, 2020
Evaluation of a clinical protocol using intranasal fentanyl for treatment of vaso-occlusive crisis in sickle cell patients in the emergency departmentHugo Paquin, Evelyne D Trottier, Yves Pastore, et al.
Paediatrics & Child Health|February 23, 2019
Oral morphine protocol evaluation for the treatment of vaso-occlusive crisis in paediatric sickle cell patientsHugo Paquin, Evelyne D Trottier, Nancy Robitaille, et al.
Cardiology in the Young|November 15, 2016
Impact of sickle cell anaemia on cardiac chamber size in the paediatric populationPhilippe M Adjagba, Gaston Habib, Nancy Robitaille, et al.
American Journal of Human Genetics|July 5, 2003
Mutations of von Hippel-Lindau tumor-suppressor gene and congenital polycythemiaYves Pastore, Katerina Jedlickova, Yongli Guan, et al.
The Journal of Pediatric Pharmacology and Therapeutics : JPPT : the Official Journal of PPAG|August 23, 2021
Evaluation of Vaso-occlusive Crisis Management With Patient-Controlled Analgesia in Children With Sickle Cell Disease Requiring HospitalizationClaire Arbitre, Yves Pastore, Benoit Bailey, et al.
Ejhaem|February 20, 2026
Transition Readiness Assessment Questionnaire: A Tool Associated With Transfer Success for Adolescents and Young Adults Living With Sickle Cell Disease?Sophie Marsolais, Yves Pastore, Nancy Robitaille, et al.
International Journal of Pharmaceutics|October 30, 2025
3D printed hydroxyurea for pediatric use: toward personalized formulations and reduced exposure riskJean Laverdière, Carlos Bendicho-Lavilla, Louiza Mahrouche, et al.
Journal of Pediatric Hematology/Oncology|March 4, 2021
Is Busulfan Clearance Different in Patients With Sickle Cell Disease? Let's Clear Up That Case With Some ControlsAmandine Remy, Yves Théorêt, Marc Ansari, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
The Journal of Allergy and Clinical Immunology. in Practice|June 29, 2023
A novel variant in caspase recruitment domain family member 11 highlights the variability of clinical manifestations and management in a three generation familyGuilhem Cros, Hugo Chapdelaine, Pierre Teira, et al.
British Journal of Clinical Pharmacology|June 14, 2020
The timing of cyclic cytotoxic chemotherapy can worsen neutropenia and neutrophiliaMichael C Mackey, Sanja Glisovic, Jean-Marie Leclerc, et al.
Paediatrics & Child Health|August 9, 2020
Evaluation of a clinical protocol using intranasal fentanyl for treatment of vaso-occlusive crisis in sickle cell patients in the emergency departmentHugo Paquin, Evelyne D Trottier, Yves Pastore, et al.
Paediatrics & Child Health|February 23, 2019
Oral morphine protocol evaluation for the treatment of vaso-occlusive crisis in paediatric sickle cell patientsHugo Paquin, Evelyne D Trottier, Nancy Robitaille, et al.
Cardiology in the Young|November 15, 2016
Impact of sickle cell anaemia on cardiac chamber size in the paediatric populationPhilippe M Adjagba, Gaston Habib, Nancy Robitaille, et al.
American Journal of Human Genetics|July 5, 2003
Mutations of von Hippel-Lindau tumor-suppressor gene and congenital polycythemiaYves Pastore, Katerina Jedlickova, Yongli Guan, et al.
The Journal of Pediatric Pharmacology and Therapeutics : JPPT : the Official Journal of PPAG|August 23, 2021
Evaluation of Vaso-occlusive Crisis Management With Patient-Controlled Analgesia in Children With Sickle Cell Disease Requiring HospitalizationClaire Arbitre, Yves Pastore, Benoit Bailey, et al.
Ejhaem|February 20, 2026
Transition Readiness Assessment Questionnaire: A Tool Associated With Transfer Success for Adolescents and Young Adults Living With Sickle Cell Disease?Sophie Marsolais, Yves Pastore, Nancy Robitaille, et al.
International Journal of Pharmaceutics|October 30, 2025
3D printed hydroxyurea for pediatric use: toward personalized formulations and reduced exposure riskJean Laverdière, Carlos Bendicho-Lavilla, Louiza Mahrouche, et al.
Journal of Pediatric Hematology/Oncology|March 4, 2021
Is Busulfan Clearance Different in Patients With Sickle Cell Disease? Let's Clear Up That Case With Some ControlsAmandine Remy, Yves Théorêt, Marc Ansari, et al.
Pageof 4